Organogenesis (ORGO) Analyst & Key Data

Analyst Consensus

Buy4 analysts

Buy

Updated Sep 12, 2026

Total Analysts4

Buy

4

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.49

Median Target+185.23%

$4.25

Potential upside vs current price

DCF Value+80.94%

$2.70

Potential upside vs current price

Current Stock Price

$1.49

Median Target+185.23%

$4.25

Potential upside vs current price

DCF Value+80.94%

$2.70

Potential upside vs current price

Analyst Consensus

Buy4 analysts

Buy

Updated Sep 12, 2026

Total Analysts4

Buy

4

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.49

Median Target+185.23%

$4.25

Potential upside vs current price

DCF Value+80.94%

$2.70

Potential upside vs current price

Current Stock Price

$1.49

Median Target+185.23%

$4.25

Potential upside vs current price

DCF Value+80.94%

$2.70

Potential upside vs current price

Organogenesis Holdings Inc.